Drug-resistant superbug infections have been called a developing nightmare that make conquered germs once again untreatable.
So there's some surprising news in a federal report released Wednesday: US superbug deaths appear to be going down.
The Centers for Disease Control and Prevention estimated about 36,000 Americans died from drug-resistant infections in 2017. That's down 18% from 2013. Officials credit an intense effort in hospitals to control the spread of particularly dangerous infections.
But while deaths are going down, the report says infections overall increased nationally. And while superbugs mainly have been considered a hospital problem, they are appearing much more often elsewhere.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
